This inventor holds 2 USPTO granted patents. Top assignees: Genmont Biotechnology Co., Globoasia, LLC. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: Innovations by Ching-Hsiang Hsu
Introduction
Ching-Hsiang Hsu is a notable inventor based in Taibao, Taiwan. He has made significant contributions to the field of immunology through his innovative inventions. With a total of 2 patents, Hsu's work focuses on developing treatments for allergies and immunological disorders.
Latest Patents
Hsu's latest patents include groundbreaking inventions aimed at improving health outcomes. The first patent is for "Live vaccines for allergy treatment," which involves transformed bacteria that contain a DNA molecule encoding a protein allergen, along with a promoter operably linked to the nucleotide sequence. The second patent is for "Herbal compositions for treating immunological disorders." This invention provides pharmaceutical compositions that include various Chinese herbs, which are particularly effective in treating conditions such as asthma, atopic eczema, atopic dermatitis, allergic rhinitis, and rheumatoid arthritis. The compositions feature ingredients like ophiopogon, pinellia, raw licorice, tang-shen, American ginseng, and specific herbs found only in Taiwan.
Career Highlights
Throughout his career, Hsu has worked with several companies, including Globoasia, L.L.C. and Genmont Biotechnology Co. His innovative approach and dedication to research have positioned him as a key figure in the field of biotechnology.
Collaborations
Hsu has collaborated with notable coworkers, including Shuenn-Jyi Sheu and Yuh-Chyang Charng, who have contributed to his research endeavors.
Conclusion
Ching-Hsiang Hsu's contributions to immunology through his patents and collaborations highlight his commitment to advancing medical science. His innovative solutions continue to pave the way for effective treatments in allergy and immunological disorder management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile